Connecting to SEC EDGAR… PricingSign in
← All filings

VBIO

Valion Bio, Inc. SEC filings
Pharmaceutical Preparations · Nasdaq · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for VBIO right now.
Filing history
2026-11-05
Current report 8-K
Exec/director change
Filing ↗
2026-11-02
Current report 8-K
Exec/director changeOther event
Filing ↗
2026-10-29
Current report 8-K
Other event
Filing ↗
2026-10-27
Current report 8-K
Material agreementShare sale (dilution)
Filing ↗
2026-10-26
Current report 8-K
Other event
Filing ↗
2026-10-22
Current report 8-K
Other event
Filing ↗
2026-10-21
Prospectus 424B3
Filing ↗
2026-10-20
EFFECT EFFECT
Filing ↗
2026-10-20
EFFECT EFFECT
Filing ↗
2026-10-16
Shelf registration (future share sales) S-3
Filing ↗
2026-10-16
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-10-15
Current report 8-K
Other event
Filing ↗
2026-10-14
Current report 8-K
Other event
Filing ↗
2026-10-08
Current report 8-K
Material agreementShare sale (dilution)
Filing ↗
2026-10-08
Shelf registration (future share sales) S-3
Filing ↗
2026-10-06
Current report 8-K
Other event
Filing ↗
2026-10-05
DRS DRS
Filing ↗
2026-10-02
PRE 14A PRE 14A
Filing ↗
2026-10-01
Current report 8-K
Other event
Filing ↗
2026-09-24
Insider trade 4
Filing ↗
2026-09-24
Insider trade 4
Filing ↗
2026-09-23
Current report 8-K
Exec/director changeReg FD disclosure
Filing ↗
2026-09-17
New insider's holdings 3
Filing ↗
2026-09-17
New insider's holdings 3
Filing ↗
2026-09-04
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-09-03
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-09-02
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-09-01
Current report 8-K
Material agreementShare sale (dilution)Exec/director changeReg FD disclosure
Filing ↗
2026-08-27
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-08-27
Current report 8-K
Shareholder rights changeBylaws changeReg FD disclosure
Filing ↗
2026-08-24
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-08-24
RW RW
Filing ↗
2026-08-20
Current report (amended) 8-K/A
Shareholder vote
Filing ↗
2026-08-19
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-08-17
Current report 8-K
Share sale (dilution)Exec/director changeShareholder voteOther event
Filing ↗
2026-08-14
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-08-14
Quarterly report 10-Q
Filing ↗
2026-08-12
EFFECT EFFECT
Filing ↗
2026-08-11
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-08-06
Current report 8-K
Material agreementShare sale (dilution)Other event
Filing ↗